Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Atea Pharmaceuticals
AVIR
$403M
| $6.45M | ﹤0.01% |
1,924,773
-85,030
| -4% | -$308K |
|
2627
Bausch Health
BHC
$2.38B
| $6.45M | ﹤0.01% |
636,082
+108,269
| +21% | +$714K |
|
|
FLIC
2628
DELISTED
First of Long Island Corp
FLIC
| $6.45M | ﹤0.01% |
500,881
+14,736
| +3% | +$180K |
|
2629
Editas Medicine
EDIT
$438M
| $6.44M | ﹤0.01% |
1,887,696
-78,126
| -4% | -$340K |
|
2630
Sutro Biopharma
STRO
$425M
| $6.43M | ﹤0.01% |
185,696
+13,202
| +8% | +$517K |
|
2631
Bridgewater Bancshares
BWB
$594M
| $6.38M | ﹤0.01% |
450,451
-2,978
| -0.7% | -$39.9K |
|
2632
Avita Medical
RCEL
$236M
| $6.37M | ﹤0.01% |
594,436
+8,361
| +1% | +$78.5K |
|
2633
KRONOS Worldwide
KRO
$976M
| $6.37M | ﹤0.01% |
511,570
+683
| +0.1% | +$7.9K |
|
2634
Oil States International
OIS
$532M
| $6.36M | ﹤0.01% |
1,381,544
-12,565
| -0.9% | -$60.2K |
|
2635
Hallador Energy
HNRG
$756M
| $6.35M | ﹤0.01% |
672,801
+27,093
| +4% | +$193K |
|
2636
Getty Images
GETY
$202M
| $6.34M | ﹤0.01% |
1,663,955
+88,533
| +6% | +$312K |
|
2637
SGHC Ltd
SGHC
$6.54B
| $6.33M | ﹤0.01% |
1,742,924
+14,507
| +0.8% | +$50K |
|
2638
Voyager Therapeutics
VYGR
$197M
| $6.32M | ﹤0.01% |
1,079,509
+6,740
| +0.6% | +$49K |
|
2639
Pagaya Technologies
PGY
$1.8B
| $6.31M | ﹤0.01% |
596,992
+43,068
| +8% | +$566K |
|
2640
Foghorn Therapeutics
FHTX
$373M
| $6.31M | ﹤0.01% |
677,386
+146,276
| +28% | +$1.06M |
|
2641
Riley Exploration Permian
REPX
$804M
| $6.31M | ﹤0.01% |
237,996
+41,020
| +21% | +$1.13M |
|
2642
Talkspace
TALK
$878M
| $6.3M | ﹤0.01% |
3,014,289
-42,397
| -1% | -$82.7K |
|
|
TBCH
2643
Turtle Beach Corp
TBCH
$252M
| $6.29M | ﹤0.01% |
410,081
-7,818
| -2% | -$114K |
|
2644
Akebia Therapeutics
AKBA
$237M
| $6.28M | ﹤0.01% |
4,754,464
+218,172
| +5% | +$291K |
|
2645
Regional Management Corp
RM
$291M
| $6.28M | ﹤0.01% |
191,823
+6,288
| +3% | +$195K |
|
|
GES
2646
DELISTED
Guess Inc
GES
| $6.27M | ﹤0.01% |
311,496
+19,750
| +7% | +$419K |
|
2647
Celestica
CLS
$36.4B
| $6.24M | ﹤0.01% |
109,915
+8,660
| +9% | +$448K |
|
2648
Ocugen
OCGN
$437M
| $6.23M | ﹤0.01% |
6,278,554
+373,555
| +6% | +$513K |
|
2649
Ooma
OOMA
$593M
| $6.23M | ﹤0.01% |
546,518
+4,683
| +0.9% | +$46.3K |
|
2650
Alamos Gold
AGI
$14B
| $6.22M | ﹤0.01% |
299,612
+29,933
| +11% | +$549K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.